BRIEF published on 01/23/2025 at 18:50, 3 months 11 days ago GenSight Biologics: Financial Report and Outlook GenSight Biologics Capital Increases LUMEVOQ® Compassionate Access Treasury 2024
BRIEF published on 01/23/2025 at 18:50, 3 months 11 days ago GenSight Biologics : Bilan Financier et Perspectives GenSight Biologics LUMEVOQ® Augmentations De Capital Accès Compassionnel Trésorerie 2024
PRESS RELEASE published on 01/23/2025 at 18:45, 3 months 11 days ago Inside Information / News release on accounts, results GenSight Biologics reports end-of-year cash position and provides business update, including successful capital increases and ongoing review of LUMEVOQ dossier Business Update Cash Position GenSight Biologics Capital Increases LUMEVOQ Dossier
PRESS RELEASE published on 01/23/2025 at 18:45, 3 months 11 days ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie sa situation financière 2024 et donne des mises à jour sur ses activités, y compris le financement et la progression réglementaire de LUMEVOQ. La trésorerie s'élève à 2,5M€ à fin 2024 Financement Trésorerie Situation Financière GenSight Biologics LUMEVOQ
BRIEF published on 01/15/2025 at 07:35, 3 months 19 days ago GenSight Biologics publie les résultats à long terme de LUMEVOQ® Thérapie Génique GenSight Biologics LUMEVOQ® Acuité Visuelle Neuropathie Optique Héréditaire De Leber
BRIEF published on 01/15/2025 at 07:35, 3 months 19 days ago GenSight Biologics Reports Long-Term Results for LUMEVOQ® Gene Therapy GenSight Biologics LUMEVOQ® Visual Acuity Leber's Hereditary Optic Neuropathy
PRESS RELEASE published on 01/15/2025 at 07:30, 3 months 19 days ago Informations privilégiées / Autres communiqués GenSight Biologics annonce les résultats cliniques à 5 ans de la thérapie génique LUMEVOQ chez les patients atteints de NOHL, démontrant une amélioration bilatérale de l'acuité visuelle et un profil de sécurité favorable Thérapie Génique GenSight Biologics NOHL LUMEVOQ Résultats Cliniques
PRESS RELEASE published on 01/15/2025 at 07:30, 3 months 19 days ago Inside Information / Other news releases GenSight Biologics announces the publication of 5-year outcomes for patients treated with LUMEVOQ® gene therapy, showing sustained bilateral improvement in visual acuity and favorable safety profile Gene Therapy GenSight Biologics LUMEVOQ Visual Acuity Safety Profile
BRIEF published on 01/13/2025 at 11:31, 3 months 21 days ago Heights Capital Management exceeds 5% stake in GenSight Biologics Capital Increase Shares And Voting Rights GenSight Biologics Heights Capital Management Capital Participation
BRIEF published on 01/13/2025 at 11:31, 3 months 21 days ago Heights Capital Management dépasse 5% du capital de GenSight Biologics Augmentation De Capital GenSight Biologics Actions Et Droits De Vote Heights Capital Management Participation Capital
Published on 05/03/2025 at 03:40, 1 day 2 hours ago Snipp Interactive Announces Delay in Filing Audited Fiscal 2024 Financial Statements
Published on 05/03/2025 at 03:00, 1 day 2 hours ago Vision Marine Technologies Inc. Announces Postponement of Annual Meeting of Shareholders
Published on 05/03/2025 at 02:06, 1 day 3 hours ago Battery X Metals Achieves Pivotal Milestone with Delivery of Next-Generation Lithium-Ion Battery Rebalancing Machine and Announces Exclusive Live Reveal Event
Published on 05/02/2025 at 23:30, 1 day 6 hours ago RE Royalties Announces Fiscal 2024 Year End Results and Highlights
Published on 05/02/2025 at 15:00, 1 day 14 hours ago Newsmax #1 in Cable News for Key Demo Ratings Growth
Published on 05/03/2025 at 07:57, 22 hours ago EQS-Adhoc: Vitruvia Medical AG: Year End results as of December 31,2024
Published on 05/02/2025 at 19:00, 1 day 10 hours ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 05/02/2025 at 18:41, 1 day 11 hours ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 05/02/2025 at 17:35, 1 day 12 hours ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 04/30/2025 at 19:14, 3 days 10 hours ago Report de la publication des résultats annuels 2024
